DPP4 and acute respiratory distress syndrome: A higher risk of in-hospital death, intensive care unit (ICU) admission, and progression to acute respiratory distress syndrome (ARDS) was found to be linked with the use of DPP4 inhibitors for the chronic management of type 2 diabetes [217].